SiNtx Technologies Inc (SINT)

[boston745]

Reverse Splits have decimated longterm value yes but that happened not because the company wasnt viable but because of a conspiracy of funds that have been manipulating, with help and sometimes illegally, the stock.

Even if Sintx was back to making 20m a year in revenue it'll still need more cash. Medical science products take significant investment and Sintx has a plethora of products to bring to market across many billion dollar markets. It needs its partners to step up and then it could raise cash while the stock price is increasing instead of decreasing. However Sintx isnt designed to be a standalone company, its designed to be acquired one day. Whether thats a straight path or not is still to be determined.

You forgot a couple of things in your list of few changes. New CEO who is more business oriented who was CEO when Sintx went public. He likely aided Sintx increasing revenue so it could go public. Dr Bal is a R&D oriented CEO and did an exceptional job overseeing development of IP. Just wish hed have brought some additional products to market during his time. Another thing you forgot to mention is they brought back Gregg R. Honigblum. Mr Honigblum was a key player in helping Sintx raise funds while it was private. The fact that he's returned along with the stock buyback, the fact that employee share plan gives employees up to 25% of the company shares outstanding assuming buyback was fully successful, suggests alot is changing. Meanwhile they are looking at M&A which could include them merging with NedMedical or at least investing in that company. To do that significant increase in stockprice will be required.
Then theres the fact that Lind Partners, which is part of that conspiracy of hedge funds, updated its warrant holdings at the same time the company announced buyback almost as if the company told Lind it was going to do the buyback and thats why the SEC filing was 7.01. Half Linds warrants expire August 2025 at a strike price of $50. Thats only a marketcap of ~50m or so which is a pittance compared to Sintx true value.

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

We already know Sintx and Morgan were working together. If there is going to be some sort of NP/Sintx merger, that just solidifies it. We also know Zimmer Biomet and Sintx have had a long standing relationship (going on 20 years) so as long as Sintx components for Arthroplasty are any good, Zimmer Biomet will come out from behind the curtain. With ZB comes ZimVie and I believe Solventum because of Bryan Hanson. Leaving only Cardinal Health which is suggested by Sintx hiring of Joseph Palomo who joined Sintx from Cardinal Health R&D division.

Morgan Ceramics = Aerospace products
Zimmer Biomet = Arthroplasty oriented products
ZimVie = Dental?
Solventum = Wound Care, Catheters, & possibly Cancer treatment products.
Ned Medical = Microspheres for cancer treatment
Cardinal Health = PPE & Medical protection apparel.
NP Aerospace = Armor plates & other possible products connected to TA&T.

========================================

Markets Si3n4/Sintx Ceramics can be used in (not comprehensive)

Otho Market = $64 billion
Personal Protective Equipment market = $79.53 billion
Global Catheter market = $55bn
Antibacterial market = $44.5bn
Wound Care market = $22.25bn
Biosensors Market = $28.9bn
Condom Market = $11.6bn
Dental Implant market = $4.99bn
Armor Materials Market = $13.59bn
Cancer Treatment (microspheres) = $5-$15bn

Total = $330bn-340bn

Sources:
https://web.archive.org/web/2024040...ogger.blogspot.com/2011/05/whos-next.html?m=1
https://orthospinenews.com/2021/01/...y-2025-as-acquisitions-surge-says-globaldata/
https://www.grandviewresearch.com/industry-analysis/personal-protective-equipment-ppe-market
https://www.grandviewresearch.com/industry-analysis/catheters-market-analysis
https://www.grandviewresearch.com/industry-analysis/wound-care-market
https://www.grandviewresearch.com/industry-analysis/biosensors-market
https://www.grandviewresearch.com/industry-analysis/condom-market
https://www.mordorintelligence.com/industry-reports/armor-materials-market
https://www.grandviewresearch.com/industry-analysis/dental-implants-market
https://www.youtube.com/watch?v=KeSa5vCj6Kw